(4-fluoro-3-iodobenzyl)guanidine has been researched along with astatine in 1 studies
| Studies ((4-fluoro-3-iodobenzyl)guanidine) | Trials ((4-fluoro-3-iodobenzyl)guanidine) | Recent Studies (post-2010) ((4-fluoro-3-iodobenzyl)guanidine) | Studies (astatine) | Trials (astatine) | Recent Studies (post-2010) (astatine) |
|---|---|---|---|---|---|
| 7 | 0 | 1 | 327 | 1 | 91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larsen, RH; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
1 other study(ies) available for (4-fluoro-3-iodobenzyl)guanidine and astatine
| Article | Year |
|---|---|
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Binding Sites; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Neuroblastoma; Tissue Distribution; Tumor Cells, Cultured | 1997 |